ARTICLE | Company News
Noven, Rhône-Poulenc Rorer Inc. sales and marketing update
December 11, 1995 8:00 AM UTC
RPR began selling Menorest, transdermal 17-beta estradiol hormone replacement therapy, in France, Spain and the U.K. Menorest is available in doses of 37.5 and 75 µg per day. The product was developed...